Moreover, the presence of epigenetic and transcriptional changes observed in both BOS and AML-ASXL1 samples serve to highlight the strong and consistent effect of ASXL1 on gene expression, which supersedes even the effects of tissue [28] and disease [51, 83]. The gene discussed is ASXL1; the disease is acute myeloid leukemia.